tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JNJ Stock Latest News

Government deals lift overhang on pharma group, says BofA
The FlyGovernment deals lift overhang on pharma group, says BofA
7h ago
AZN
BMY
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe Fly
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
3d ago
AZN
BMY
Johnson & Johnson announces FDA approval of TRUFILL n-BCA Liquid Embolic System
PremiumThe Fly
Johnson & Johnson announces FDA approval of TRUFILL n-BCA Liquid Embolic System
4d ago
JNJ
Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs
PremiumThe Fly
Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs
4d ago
JNJ
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
PremiumThe Fly
Johnson and Johnson’s Rybrevant Faspro combination in NSCLC approved by FDA
4d ago
JNJ
HALO
Johnson & Johnson announces FDA approved Rybrevant in NSCLC patients
PremiumThe FlyJohnson & Johnson announces FDA approved Rybrevant in NSCLC patients
5d ago
JNJ
3 Best ETFs to Invest In, According to AI Analyst, 12/17/2025
Premium
Market News
3 Best ETFs to Invest In, According to AI Analyst, 12/17/2025
5d ago
IYH
JNJ
Johnson & Johnson price target raised to $240 from $230 at RBC Capital
Premium
The Fly
Johnson & Johnson price target raised to $240 from $230 at RBC Capital
5d ago
JNJ
Johnson & Johnson Rival Medline Pulls Off $6B IPO, Topping 2025 Deal Table
PremiumMarket News
Johnson & Johnson Rival Medline Pulls Off $6B IPO, Topping 2025 Deal Table
5d ago
BX
CG
3 Best ETFs to Invest In, According to AI Analyst, 12/15/2025
PremiumMarket News
3 Best ETFs to Invest In, According to AI Analyst, 12/15/2025
7d ago
JNJ
MCK
Johnson & Johnson price target raised to $220 from $204 at BofA
PremiumThe Fly
Johnson & Johnson price target raised to $220 from $204 at BofA
7d ago
JNJ
Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential
PremiumRatings
Balanced Risk-Reward Profile for Johnson & Johnson Amid Limited Stock Re-Rating Potential
7d ago
JNJ
Johnson & Johnson announces FDA approved sNDA for AKEEGA plus prednisone
PremiumThe FlyJohnson & Johnson announces FDA approved sNDA for AKEEGA plus prednisone
8d ago
JNJ
FDA approves J&J’s Akeega BRCA2-mutated prostate cancer
Premium
The Fly
FDA approves J&J’s Akeega BRCA2-mutated prostate cancer
10d ago
JNJ
Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley
Premium
The Fly
Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley
10d ago
JNJ
Johnson & Johnson price target raised to $230 from $209 at RBC Capital
PremiumThe Fly
Johnson & Johnson price target raised to $230 from $209 at RBC Capital
11d ago
JNJ
Johnson & Johnson price target raised to $232 from $215 at Citi
PremiumThe Fly
Johnson & Johnson price target raised to $232 from $215 at Citi
11d ago
JNJ
Johnson & Johnson price target raised to $240 from $215 at HSBC
PremiumThe Fly
Johnson & Johnson price target raised to $240 from $215 at HSBC
12d ago
JNJ
Cautious Hold Rating for Johnson & Johnson Amid Promising Clinical Results and Competitive Challenges
PremiumRatings
Cautious Hold Rating for Johnson & Johnson Amid Promising Clinical Results and Competitive Challenges
12d ago
JNJ
Carvykti strength holds, Legend Biotech weakness overdone, says RBC Capital
PremiumThe FlyCarvykti strength holds, Legend Biotech weakness overdone, says RBC Capital
13d ago
JNJ
LEGN
Johnson & Johnson reports results from Phase 3 MajesTEC-3 study
Premium
The Fly
Johnson & Johnson reports results from Phase 3 MajesTEC-3 study
13d ago
JNJ
LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List
Premium
Market News
LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List
15d ago
JNJ
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >